A Pilot Phase 2 Study of Albumin-Bound Rapamycin Nanoparticles, ABI-009, in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors (NETs) of the Lung or Gastroenteropancreatic System Article

Web of Science: 000462541800103

Cited authors

  • Ramirez, Robert A.; Matrana, Marc; Satti, Suma; Griffin, Ryan P.; Thiagarajan, Ramcharan; Boudreaux, J. Philip; Woltering, Eugene A.

Publication date

  • 2019

Published in


International Standard Serial Number (ISSN)

  • 0885-3177

Start page

  • 449

End page

  • 449


  • 48


  • 3